| Stephen Baker |
Wellcome Trust Centre for Human Genetics |
Joint Keynote Session and Panel Discussion with Grand Challenges: Innovation in Drug Discovery |
October 18, 2018 |
| ELIZABETH A. WINZELER |
Novartis Pharmaceuticals |
Robust Target Validation – What Does it Mean? |
October 18, 2018 |
| Kelly Chibale |
University of Cape Town, |
Joint Keynote Session and Panel Discussion with Grand Challenges: Innovation in Drug Discovery |
October 18, 2018 |
| Thierry Diagana |
No affiliation recorded |
New Therapeutics for Global Health |
October 18, 2018 |
| Ken Duncan |
Discovery & Translational Sciences, Bill & Melinda Gates Foundation |
Joint Keynote Session and Panel Discussion with Grand Challenges: Innovation in Drug Discovery |
October 18, 2018 |
| Marion Koopmans |
No affiliation recorded |
Vaccine and Therapeutic Strategies |
October 18, 2018 |
| Ralph Tripp |
University of Georgia |
Vaccine and Therapeutic Strategies |
October 18, 2018 |
| Sally Davies |
Department of Health UK |
Joint Keynote Session and Panel Discussion with Grand Challenges: Innovation in Drug Discovery |
October 18, 2018 |
| Boris Striepen |
University of Pennsylvania |
Microbiology Society Annual Conference 2018 |
April 10, 2018 |
| Andrew G. Bean |
Commonwealth Scientific and Industrial Research Organization |
Influenza: Immunity and Vaccines |
October 18, 2018 |
| Sophie A. Valkenburg |
University of Hong Kong, |
Influenza: Immunity and Vaccines |
October 18, 2018 |
| Matloob Husain |
University of Otago |
Influenza: Immunity and Vaccines |
October 18, 2018 |
| Linfa Wang |
Duke-NUS Medical School |
Influenza: Immunity and Vaccines |
October 18, 2018 |
| Ted M. Ross |
No affiliation recorded |
Influenza: Immunity and Vaccines |
October 18, 2018 |
| Li-meng Yan |
University of Hong Kong, |
Influenza: Immunity and Vaccines |
October 18, 2018 |
| Stephen Whitehead |
National Institutes of Health |
Vaccine and Therapeutic Strategies |
October 18, 2018 |
| Danielle E. Anderson |
Duke-NUS Medical School |
Vaccine and Therapeutic Strategies |
October 18, 2018 |
| Nathalie Strub Wourgaft |
Drugs for Neglected Diseases Initiative |
New Therapeutics for Global Health |
October 18, 2018 |
| Lluís Ballell |
GlaxoSmithKline |
New Therapeutics for Global Health |
October 18, 2018 |
| Joseph D. Turner |
Liverpool School of Tropical Medicine |
New Therapeutics for Global Health |
October 18, 2018 |
How We Rank